These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
759 related articles for article (PubMed ID: 37018291)
1. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the inflammatory response to COVID-19 illness in pregnancy. Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19. Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG Front Immunol; 2023; 14():1170012. PubMed ID: 37063871 [TBL] [Abstract][Full Text] [Related]
4. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone. Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC Front Immunol; 2023; 14():1229611. PubMed ID: 37662953 [TBL] [Abstract][Full Text] [Related]
5. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. Petruccioli E; Najafi Fard S; Navarra A; Petrone L; Vanini V; Cuzzi G; Gualano G; Pierelli L; Bertoletti A; Nicastri E; Palmieri F; Ippolito G; Goletti D J Transl Med; 2021 Jun; 19(1):272. PubMed ID: 34174875 [TBL] [Abstract][Full Text] [Related]
6. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection. Majeed AY; Zulkafli NES; Ad'hiah AH Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685 [TBL] [Abstract][Full Text] [Related]
7. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients. Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477 [TBL] [Abstract][Full Text] [Related]
11. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113 [TBL] [Abstract][Full Text] [Related]
12. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients. Filgueira TO; Carvalho PRC; de Sousa Fernandes MS; Castoldi A; Teixeira AM; de Albuquerque RB; de Lima-Filho JL; Souto FO Front Immunol; 2022; 13():1051059. PubMed ID: 36685603 [TBL] [Abstract][Full Text] [Related]
13. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients. Mansoor S; Butt AR; Bibi A; Mushtaq S; Ullah I; Alshahrani F; Khan A; Mansoor A PLoS One; 2023; 18(9):e0291332. PubMed ID: 37756264 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417 [TBL] [Abstract][Full Text] [Related]
15. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave. Aiello A; Grossi A; Meschi S; Meledandri M; Vanini V; Petrone L; Casetti R; Cuzzi G; Salmi A; Altera AM; Pierelli L; Gualano G; Ascoli Bartoli T; Castilletti C; Agrati C; Girardi E; Palmieri F; Nicastri E; Di Rosa E; Goletti D Front Immunol; 2022; 13():920227. PubMed ID: 35967321 [TBL] [Abstract][Full Text] [Related]
16. Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients. Dos Santos JMB; do Amaral JB; França CN; Monteiro FR; Alvares-Saraiva AM; Kalil S; Durigon EL; Oliveira DBL; Rodrigues SS; Heller D; Welter EAR; Pinho JRR; Vieira RP; Bachi ALL Front Immunol; 2022; 13():890887. PubMed ID: 35686128 [TBL] [Abstract][Full Text] [Related]
18. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela. Bahgat MM; Nadeem R; Nasraa MH; Amer K; Hassan WA; ELGarhy FM; Reda S; Abd-Elshafy DN Viral Immunol; 2023 Nov; 36(9):600-609. PubMed ID: 37831918 [TBL] [Abstract][Full Text] [Related]
19. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way. Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2. Niu C; Liang T; Chen Y; Zhu S; Zhou L; Chen N; Qian L; Wang Y; Li M; Zhou X; Cui J Front Immunol; 2024; 15():1444643. PubMed ID: 39359733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]